Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook

Shanker Gupta, PhD, named PDA JPST Acting Editor-in-Chief

Please note: Some pages on PDA's main site (www.pda.org) and the PDA Letter (https://www.pda.org/pda-letter-portal/home) may not currently be available due to technical issues. The JPST site is unaffected. Thank you for your patience while PDA works to resolve the issue.


Shanker L. Gupta, PhD, is now serving as the Acting Editor-in-Chief of the PDA Journal of Pharmaceutical Science and Technology (JPST), while PDA conducts the search for a permanent Editor. Richard V. Levy, PhD, has retired as Editor-in-Chief after almost four years. Dr. Gupta joined the reconstitued Journal Editorial Board in 2019 and volunteered as an Associate Editor in 2020. In that capacity, he assisted Dr. Levy evaluate and manage JPST submissions. He has been a PDA member for more than 30 years.

Dr. Gupta has worked with the U.S. National Institutes of Health for almost 20 years, currently as a senior scientist in the Division of Cancer Prevention of the National Cancer Institute and consulting with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases. At NIH, he has been responsible for managing multiple translational projects designed to generate clinical product for use in Phase I and Phase 2 clinical trials. Gupta also collaborates with contract teams and actively participates in the design and development of formulations of several promising agents that have resulted in patent filings. He has supported over 40 IND submissions.

Dr. Gupta holds a BS (Hons) in pharmacy from the University of Florida and a PhD in pharmaceutical chemistry from the University of Michigan, Ann Arbor. Prior to joining NIH, he was a project leader in sterile products development at Abbott Laboratories and filed the IND for the expanded use of a lung surfactant product (Survanta®), which was the first product of its kind for neonatal respiratory distress syndrome. Dr. Gupta has published more than 20 papers in various peer-reviewed journals and contributed to books.

Accepted Articles

  • You have access
    Interventions Risk Evaluation and Management in Aseptic Manufacturing - A Case Study
    Hal Baseman, Subrata Chakraborty and Michael K Long
    PDA Journal of Pharmaceutical Science and Technology May 2022, pdajpst.2020.012245; DOI: https://doi.org/10.5731/pdajpst.2020.012245
  • You have access
    Container Closure Integrity Test Method Development on Vials Stored at -80°C Using Headspace Carbon Dioxide Analysis
    Ken G Victor, Allison Alix Caudill and James Veale
    PDA Journal of Pharmaceutical Science and Technology March 2022, pdajpst.2021.012641; DOI: https://doi.org/10.5731/pdajpst.2021.012641
  • You have access
    Advances in Large Volume Subcutaneous Injections: A Pilot Tolerability Study of an Innovative Needle-Free Injection Platform
    E. Lynne Kelley, Andrea Fernandes, Marc Pelletier, Eri Ashley Takami, Christine Emery, Bobby Dyer, Mary V. Jacoski, Valery Lozko, Bart Burgess and Richard H. Smith
    PDA Journal of Pharmaceutical Science and Technology March 2022, pdajpst.2021.012670; DOI: https://doi.org/10.5731/pdajpst.2021.012670
  • You have access
    A Systematic Approach for the Evaluation, Validation and Implementation of Automated Colony Counting Systems
    Sven Deutschmann, Bill Carpenter, Caroline Duignan, Chris Knutsen, Joanny Salvas, Lisa Wysocki, Lucile Plourde, Lynn Johnson, Wolfgang Eder and Margit Franz-Riethdorf
    PDA Journal of Pharmaceutical Science and Technology March 2022, pdajpst.2021.012646; DOI: https://doi.org/10.5731/pdajpst.2021.012646
  • You have access
    Do Plant Isolates have a Role in Method Suitability and Growth Promotion Testing in the Microbiology Laboratory? Is it a Matter of Science versus Compliance?
    Dennis E. Guilfoyle and Anthony M. Cundell
    PDA Journal of Pharmaceutical Science and Technology February 2022, pdajpst.2021.012675; DOI: https://doi.org/10.5731/pdajpst.2021.012675
  • You have access
    Tailored media-fill test protocols inspired by 68Ga kit-based radiopharmaceuticals
    Charlotte Donze, Lea Rubira, Pierre Olivier Kotzki, Emmanuel Deshayes and Cyril Fersing
    PDA Journal of Pharmaceutical Science and Technology February 2022, pdajpst.2021.012657; DOI: https://doi.org/10.5731/pdajpst.2021.012657
View more published ahead of print articles

Current Issue

PDA Journal of Pharmaceutical Science and Technology: 76 (3)
PDA Journal of Pharmaceutical Science and Technology
Vol. 76, Issue 3
May/June 2022
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)

Featured Articles

  • Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic
    July 31, 2020
  • Evaluation of a Novel Prefilled Syringe Concept for Ophthalmic Applications: A Formative Human...
    February 01, 2022
  • Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable...
    October 05, 2020
  • Comparison of Limulus Amoebocyte Lysate and Recombinant Factor C Assays for Endotoxin...
    July 31, 2020
  • Physicochemical Excipient-Container Interactions in Prefilled Syringes and Their Impact on Syringe...
    August 03, 2021
  • Evaluating Nitrosamines from Elastomers in Pharmaceutical Primary Packaging
    April 01, 2022
  • My Last Issue as Editor-in-Chief
    April 01, 2022

PDA President Richard Johnson's 2022 Message

2021 was a challenging year for everyone, and PDA was not an exception. Last year at this time I shared the impact that the pandemic had on PDA in 2020. We were looking forward to a brighter 2021, and in some ways it was better. Vaccines for COVID were developed, proven, and released in record speed, and our community had a significant role in making that possible.

We also brought together industry, suppliers and regulators in a joint effort to address these challenges. Nonetheless, the pandemic continued throughout 2021 and into the present year. We have had positive signs, followed by resurgence of infections and the resulting societal and human impact. For PDA, it had the effect of making us postpone our return to in-person gatherings, and shift (again) to all-virtual. Of more importance has been the staggering human cost, that as of January 27, 2022, has resulted in over 5.5 million deaths, and more than 364 million cases worldwide. In addition to the terrible health impacts, the control measures that are continuing to be implemented have affected many more people’s livelihood and social activity.

Click here to read more.

 

  • Most Cited
  • Most Read
Loading
  • Comparison of Limulus Amoebocyte Lysate and Recombinant Factor C Assays for Endotoxin Detection in Four Human Vaccines with Complex Matrices
  • Low-Volume Aseptic Filling Using a Linear Peristaltic Pump
  • Assessment of Sensor Concepts for 100% In-Process Control of Low-Volume Aseptic Fill-Finish Processes
  • Environmental and Personnel Monitoring Programs—A Risk-Based Case Study of Cutibacterium acnes
  • Pharmaceutical Manufacturing in the EU and the EU–US Mutual Recognition Agreement
More...

Back to top

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2022 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire